Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication

Pierre A Robe, Olivier Jolois, Minh N'Guyen, Frederic Princen, Brigitte Malgrange, Marie-Paule Merville, Vincent Bours

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The efficacy of HSV-TK/ganciclovir gene therapy largely relies on the bystander effect, i.e. the ability of transfected cells to kill the adjacent, untrasfected cells. This mechanism itself depends chiefly on the transfer via gap junctions of phosphorylated ganciclovir between cells, and is often deficient in glioblastomas. In this report, we demonstrate that n-butyrate markedly enhances the gap junction intercellular communication of GJIC-deficient glioma cells, and significantly increases the bystander effect in such cells. This effect of n-butyrate appears to be independent from its HDAC inhibitory effect, since trichostatin A does not reproduce it.

Original languageEnglish
Pages (from-to)187-92
Number of pages6
JournalInternational Journal of Oncology
Volume25
Issue number1
Publication statusPublished - Jul 2004

Keywords

  • Butyrates/pharmacology
  • Bystander Effect/drug effects
  • Cell Communication/physiology
  • Cell Line, Tumor
  • Connexin 43/analysis
  • Gap Junctions/physiology
  • Glioblastoma
  • Humans
  • Simplexvirus/enzymology
  • Thymidine Kinase/pharmacology

Fingerprint

Dive into the research topics of 'Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication'. Together they form a unique fingerprint.

Cite this